Indeed Snapshot

Track Regeneron Pharmaceuticals reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 29th, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 62.0 62.0 59.0 68.0 58.0 62.0 64.0 70.0 168.0 303.00 303.00 3.50 3.90 3.30 3.10 3.40 86.00 More than one month 98.00 MEDIUM 94.00 FAVORABLE Aug 29th, 2022 12:30PM Aug 29th, 2022 12:30PM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 28th, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 167.0 303.00 303.00 3.50 3.90 3.30 3.10 3.40 86.00 More than one month 98.00 MEDIUM 94.00 FAVORABLE Aug 28th, 2022 05:30AM Aug 28th, 2022 05:30AM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 27th, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 167.0 303.00 303.00 3.50 3.90 3.30 3.10 3.40 85.00 More than one month 97.00 MEDIUM 94.00 FAVORABLE Aug 27th, 2022 04:49AM Aug 27th, 2022 04:49AM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 25th, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 166.0 301.00 301.00 3.50 3.90 3.30 3.10 3.40 84.00 More than one month 96.00 MEDIUM 94.00 FAVORABLE Aug 25th, 2022 09:28AM Aug 25th, 2022 09:28AM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 23rd, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 165.0 301.00 301.00 3.50 3.90 3.30 3.10 3.40 84.00 More than one month 95.00 MEDIUM 94.00 FAVORABLE Aug 23rd, 2022 11:21AM Aug 23rd, 2022 11:21AM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 21st, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 165.0 301.00 301.00 3.50 3.90 3.30 3.10 3.40 83.00 More than one month 95.00 MEDIUM 94.00 FAVORABLE Aug 21st, 2022 01:05PM Aug 21st, 2022 01:05PM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 20th, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 165.0 301.00 301.00 3.50 3.90 3.30 3.10 3.40 83.00 More than one month 95.00 MEDIUM 94.00 FAVORABLE Aug 20th, 2022 02:43PM Aug 20th, 2022 02:43PM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 19th, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 165.0 301.00 301.00 3.50 3.90 3.30 3.10 3.40 83.00 More than one month 95.00 MEDIUM 94.00 FAVORABLE Aug 19th, 2022 01:05PM Aug 19th, 2022 01:05PM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 18th, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 72.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 165.0 301.00 301.00 3.50 3.90 3.30 3.10 3.40 83.00 More than one month 95.00 MEDIUM 94.00 FAVORABLE Aug 18th, 2022 04:49AM Aug 18th, 2022 04:49AM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:regn https://www.indeed.com/cmp/regeneron Aug 17th, 2022 12:00AM Open Regeneron Pharmaceutical & Biotechnology Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions. Mission: For 30 years, our mission has been to use the power of science to bring new medicines to patients.... over and over again. Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. RRv1_1B_5B 777 Old Saw Mill River Road Tarrytown, New York 10591 United States Leonard Schleifer 3.70 71.0 63.0 66.0 65.0 61.0 62.0 59.0 68.0 58.0 62.0 62.0 65.0 70.0 165.0 301.00 301.00 3.50 3.90 3.30 3.10 3.40 83.00 More than one month 95.00 MEDIUM 94.00 FAVORABLE Aug 17th, 2022 10:28AM Aug 17th, 2022 10:28AM Regeneron Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.